Assembly Biosciences, Inc. (ASMB): Operating Cash Flow
-$41.09M
Year ended 2025-12-31
-$38.48M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$41.09M | n/m | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | -$51.12M | n/m | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $22.74M | n/m | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | -$84.46M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$93.40M | n/m | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | -$62.96M | n/m | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | -$84.07M | n/m | 2021-02-25, From 2019-01-01 |
| 2018-12-31 | -$64.96M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $1.86M | n/m | 2020-03-04, From 2017-01-01 |
| 2016-12-31 | -$34.88M | n/m | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | -$18.70M | n/m | 2018-03-08, From 2015-01-01 |
| 2014-12-31 | -$14.97M | n/m | 2015-03-16, From 2014-01-01 |
| 2013-12-31 | -$17.80M | n/m | 2015-03-16, From 2013-01-01 |
| 2012-12-31 | -$21.38M | n/m | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | -$25.07M | n/m | 2013-03-18, From 2011-01-01 |
| 2010-12-31 | -$5.21M | n/m | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | -$3.48M | n/a | 2012-03-14, From 2009-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | -$41.09M | n/m |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | -$249.68M | n/m |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | -$276.39M | n/m |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | -$131.29M | n/m |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | -$659.0K | n/m |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | -$75.59M | n/m |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | -$64.06M | n/m |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | -$12.62M | n/m |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $10.52M | +986.1% |
Compare ASMB, BCYC, VRDN, ABCL side by side · Screen every company in Pharmaceutical Preparations ↗